DNA

Transmission Electron Microscope Market to Grow by USD 528.8 Million (2024-2028), Driven by Nanotechnology Focus, AI-Powered Market Evolution Report – Technavio

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market…

1 year ago

Air Doctor Raises $20 million Series B Round to Pioneer State-of-the-Art Digital Platform for Accessible Medical Care Abroad

Air Doctor connects travelers to a global network of over 20,000 multilingual doctors and specialists. The user-friendly app and cutting-edge…

1 year ago

Helix and WakeMed to Launch Major Genetic Health Initiative in Wake County

4-year population health program to improve preventive care and provide greater precision care SAN MATEO, Calif., and RALEIGH, N.C., Oct. 1,…

1 year ago

OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software

KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release…

1 year ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

1 year ago

Alignment Health Plan Introduces 2025 Medicare Advantage Plans to Address Diverse Care Needs of Seniors, from Cost Concerns to Chronic Conditions

Medicare beneficiaries encouraged to evaluate their plan benefits during annual enrollment period, Oct. 15-Dec. 7ORANGE, Calif., Oct. 01, 2024 (GLOBE…

1 year ago

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society

CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…

1 year ago

NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics

Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation…

1 year ago

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary…

1 year ago